Trial intelligence / Profile preview

Salbutamol pharmacokinetics in athletes with asthma at rest versus intense exercise

2009-009316-50Phase 4Active

Sponsor
Centre hospitalier universitaire de Toulouse
Start
Mar 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of salbutamol in asthma, sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoints: Difference in urinary salbutamol pharmacokinetic profile between rest and exercise and Maximum urinary salbutamol concentration. Started Mar 2009; status: active.

02

Drugs

salbutamol
03

Conditions

asthma

Beyond the preview

Go deeper on 2009-009316-50.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-009316-50.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call